SGI 2022 The 11th Annual Meeting of Society of Gastrointestinal Intervention

Invited Faculties

Session 1.
Therapeutic modalities of various esophageal diseases
  • Mohan Ramchandani Asian Institute of Gastroenterology Hospital, India CV
  • Kun Yung Kim Jeonbuk National University, Korea CV
  • Cheol Min Shin Seoul National University, Korea CV
  • Peter D. Siersema Radboud University Medical Center, The Netherlands CV
Session 2.
How to cope with ERCP/EUS related complications: Who do you call
  • In Rae Cho Seoul National University, Korea CV
  • Kenneth Binmoeller California Pacific Medical Center, USA CV
  • Sajjad Mahmood Manchester University Hospitals NHS trust, UK CV
  • Mariano E. Giménez University of Buenos Aires, Argentina CV
  • Myungsu Lee Seoul National University, Korea CV
Session 3.
Role of EUS for diagnosis and treatment of pancreatic cystic neoplasms
  • Jae Seok Bae Seoul National University, Korea CV
  • Eun Ji Shin The Johns Hopkins University, USA CV
  • Sang Hyub Lee Seoul National University, Korea CV
  • Mariano E. Giménez University of Buenos Aires, Argentina CV
Session 4.
Malignant obstruction at the level of the distal duodenum:
What is the most effective modality?
  • Louis M. Wong Kee Song Mayo Clinic, USA CV
  • Jong Hyouk Yun Kosin University, Korea CV
  • Kenneth F. Binmoeller California Pacific Medical Center, USA CV
  • Chung-Sik Gong University of Ulsan, Korea CV
Session 5.
The 20 most important studies in current management of advanced HCC
  • Tatsuya Yamashita Kanazawa University, Korea CV
  • Jinsoo Rhu Sungkyunkwan University, Korea CV
  • Edward Kim The Mount Sinai Hospital, USA CV
  • Jinhong Jung University of Ulsan, Korea CV
Session 6.
Cutting edge of diagnostic and therapeutic approach for Crohn's disease
  • Su Hwan Kim Seoul Nationla University, Korea CV
  • Ji Yeon Ha Hallym University, Korea CV
  • Naoki Hosoe Keio University, Japan CV
  • Jinsu Kim The Catholic University of Korea, Korea CV
  • Min Soo Cho Yonsei University, Korea CV
Session 7.
Management of small bowel tumor
  • Eun Ji Shin The Johns Hopkins University, USA CV
  • Jin Sil Kim Ewha Womans University, Korea CV
  • Jeffrey H. Lee MD Anderson Cancer Center, USA CV
  • Inja Park University of Ulsan, Korea CV
Session 8.
Management of solitary large HCC
  • Su Jong Yu Seoul National University, Korea CV
  • Dong Jin Joo Yonsei University, Korea CV
  • Toshihiro Tanaka Osaka University, Japan CV
  • Rheun-Chuan Lee Taipei Veterans General Hospital, Taiwan CV
  • Jeong Il Yu Sungkyunkwan University, Korea CV
Session 9.
Cutting edge of management of obscure GI bleeding
  • Charles Y. Kim Duke University, USA CV
  • Sang Hoon Kim Dongguk University Korea CV
  • Joon Ho Kwon Yonsei University, Korea CV
  • Seung-Bum Ryoo Seoul National University, Korea CV
Session 10.
Hepatocellular carcinoma with bile duct invasion
  • Jonggi Choi University of Ulsan, Korea CV
  • Kwang Hyun Chung Eulji University, Korea CV
  • Dai Hoon Han Yonsei University, Korea CV
  • Shiro Miyayama ukui-ken Saiseikai Hospital, Japan CV
  • Sang Min Yoon University of Ulsan, Korea CV
Copyright 2022 SGI. All rights reserved. The Society of Gastrointestinal Intervention (SGI)
Address: 7F, Venture Castle Bldg., 12 Hakdong-ro 31-gil, Gangnam-gu, 06052, Korea
Registration Number: 215-82-64752
Secretariat of SGI 2022
Tel. +82-31-903-4385 (Registration. +82-31-906-4388)
Email. sgi@conventionpm.com

Privacy Policy